(Q37208157)

18 August 2017

De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis (English)

1 reference

18 August 2017

0 references

1 reference

1 reference

1 reference

1 reference

Jiang-Shan Lian

1

1 reference

18 August 2017

Lin-Yan Zeng

2

1 reference

18 August 2017

Jian-Yang Chen

3

1 reference

18 August 2017

Hong-Yu Jia

4

1 reference

18 August 2017

Yi-Min Zhang

5

1 reference

18 August 2017

Dai-Rong Xiang

6

1 reference

18 August 2017

Liang Yu

7

1 reference

18 August 2017

Jian-Hua Hu

8

1 reference

18 August 2017

Ying-Feng Lu

9

1 reference

18 August 2017

Ling Zheng

10

1 reference

18 August 2017

Lan-Juan Li

11

1 reference

18 August 2017

Yi-Da Yang

12

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 October 2013

1 reference

World Journal of Gastroenterology

18 August 2017

1 reference

18 August 2017

19

1 reference

18 August 2017

37

1 reference

18 August 2017

6278-6283

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Treatment of hepatitis B in decompensated liver cirrhosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Drug safety evaluation of adefovir in HBV infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Monotherapy versus combination therapy for the treatment of chronic hepatitis B.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Diagnosis and epidemiology of cirrhosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Hepatocellular carcinoma--epidemiological trends and risk factors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Lamivudine for patients with chronic hepatitis B and advanced liver disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Management of patients with decompensated HBV cirrhosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Characteristics of patients with cirrhosis who are discharged from the hospital against medical advice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Adefovir dipivoxil for wait-listed and post–liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3787360

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24115827

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3748/WJG.V19.I37.6278

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

24115827

1 reference